These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25166458)

  • 21. Psychopharmacological medication use among older adults with dementia in nursing homes.
    Brandt NJ; Pythtila J
    J Gerontol Nurs; 2013 Apr; 39(4):8-14. PubMed ID: 23616986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliciting goals of care in a nursing home.
    Furman CD; Kelly SE; Knapp K; Mowery RL; Miles T
    J Am Med Dir Assoc; 2007 Mar; 8(3 Suppl 2):e35-41. PubMed ID: 17352984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff.
    Lemay CA; Mazor KM; Field TS; Donovan J; Kanaan A; Briesacher BA; Foy S; Harrold LR; Gurwitz JH; Tjia J
    J Am Med Dir Assoc; 2013 Dec; 14(12):895-900. PubMed ID: 24074962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia.
    Bonner AF; Field TS; Lemay CA; Mazor KM; Andersen DA; Compher CJ; Tjia J; Gurwitz JH
    J Am Geriatr Soc; 2015 Feb; 63(2):302-8. PubMed ID: 25643635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
    Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
    Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the Relative Contribution of Resident Versus Facility Characteristics Associated With Antipsychotic Medication Receipt Among Nursing Facility Residents.
    Busch SH; Cohen MS; Konetzka RT
    Med Care; 2019 Oct; 57(10):822-829. PubMed ID: 31415339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes.
    Tjia J; Lemay CA; Bonner A; Compher C; Paice K; Field T; Mazor K; Hunnicutt JN; Lapane KL; Gurwitz J
    J Am Geriatr Soc; 2017 Jan; 65(1):59-65. PubMed ID: 27550398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations.
    Becker ER; Constantine RJ; McPherson MA; Jones ME
    J Health Care Finance; 2013; 40(1):40-67. PubMed ID: 24199518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use.
    Baier RR; Mor V
    Isr J Health Policy Res; 2017; 6():5. PubMed ID: 28149500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.
    Kleijer BC; van Marum RJ; Frijters DH; Jansen PA; Ribbe MW; Egberts AC; Heerdink ER
    Int Psychogeriatr; 2014 Mar; 26(3):363-71. PubMed ID: 24252349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of facility characteristics on use of antipsychotic medications in nursing homes.
    Hughes CM; Lapane KL; Mor V
    Med Care; 2000 Dec; 38(12):1164-73. PubMed ID: 11186295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMS seeks to reduce antipsychotic use in nursing home residents with dementia.
    Mitka M
    JAMA; 2012 Jul; 308(2):119, 121. PubMed ID: 22782393
    [No Abstract]   [Full Text] [Related]  

  • 34. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.
    Thompson Coon J; Abbott R; Rogers M; Whear R; Pearson S; Lang I; Cartmell N; Stein K
    J Am Med Dir Assoc; 2014 Oct; 15(10):706-18. PubMed ID: 25112229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.
    Mort JR; Sailor R; Hintz L
    S D Med; 2014 Feb; 67(2):67-9. PubMed ID: 24624602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes.
    Gerlach LB; Maust DT; Kales HC; Chang M; Kim HM; Wiechers IR; Zivin K
    Am J Psychiatry; 2022 Aug; 179(8):544-552. PubMed ID: 35615813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioural and psychological symptoms of dementia and their management in care homes within the East of England: a postal survey.
    Backhouse T; Killett A; Penhale B; Burns D; Gray R
    Aging Ment Health; 2014 Mar; 18(2):187-93. PubMed ID: 23886404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic Alternatives to Antipsychotic Medications in Treating Dementia Behaviors: An Evidence-Based Practice Protocol.
    Birtley NM
    J Psychosoc Nurs Ment Health Serv; 2016 Oct; 54(10):46-53. PubMed ID: 27699426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic prescribing in nursing homes: an audit report.
    Morrison A
    Qual Prim Care; 2009; 17(5):359-62. PubMed ID: 20003722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Does Medicaid Reimbursement Impact Nursing Home Quality? The Effects of Small Anticipatory Changes.
    Bowblis JR; Applebaum R
    Health Serv Res; 2017 Oct; 52(5):1729-1748. PubMed ID: 27581748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.